Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

8
Number of overlapping holdings
12.5%
% of XLV's 64 holdings also in IHE
23.5%
% of IHE's 34 holdings also in XLV
Overlap by Weight
Sector Drift (XLV minus IHE)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in XLV |
Weight in IHE |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 9.7% | 26.1% | 9.7% | |
JOHNSON & JOHNSON | 7.5% | 23.4% | 7.5% | |
MERCK & CO. INC. | 5.3% | 4.7% | 4.7% | |
PFIZER INC | 3.5% | 4.3% | 3.5% | |
BRISTOL-MYERS SQUIBB CO | 2.1% | 4.1% | 2.1% |
Position Highlights (Non-Overlapping Exposures)
XLV Overweight Relative to IHE
UNITEDHEALTH GROUP INC | 10.3% | |
ABBVIE INC | 5.0% | |
THERMO FISHER SCIENTIFIC INC | 3.9% | |
ABBOTT LABORATORIES | 3.7% | |
DANAHER CORP | 3.0% | |
AMGEN INC | 2.9% | |
ANTHEM INC | 2.3% | |
INTUITIVE SURGICAL INC | 2.3% | |
MEDTRONIC PLC | 2.1% | |
STRYKER CORP | 2.0% |
XLV Underweight Relative to IHE
ELI LILLY & CO | -16.3% | |
JOHNSON & JOHNSON | -16.0% | |
ROYALTY PHARMA PLC CLASS A | -4.6% | |
VIATRIS, INC. | -4.3% | |
JAZZ PHARMACEUTICALS PLC | -3.4% | |
ZOETIS INC | -3.0% | |
CATALENT INC | -3.0% | |
ELANCO ANIMAL HEALTH, INC. | -2.6% | |
INTRA-CELLULAR THERAPIES INC | -2.3% | |
BRISTOL-MYERS SQUIBB CO | -1.9% |